Skip to main content
. 2020 Jan 28;19(3):395–402. doi: 10.1007/s42000-020-00176-z

Table 1.

Anthropometric data and baseline laboratory parameters

Control subjects (n = 10) PKU subjects (n = 12) p
Age (years) 26 (24.7–27) 26 (20.2–36.7) 0.958
Height (cm) 181 (175.6–184.3) 179.3 (174.6–183.5) 0.615
Weight (kg) 74.7 (66.4–87.7) 69.5 (65.8–80) 0.221
BMI (kg/m2) 22.5 (21.6–26.7) 23.15(20.3–25.2) 0.710
Body fat (%) 16.6 (13.8–20.9) 16.1 (11.9–25.5) 0.909
Body muscle (%) 47.3 (45.3–48.5) 47.5 (42.1–49.3) 0.497
Body bone (%) 4.6 (4.4–4.8) 4.5 (4–4.8) 0.328
Residual (%) 31.3 (29.1–32.5) 31.3 (29.1–32.5) 0.949
Resting HR (beats/min) 68.5 (57.2–76) 63 (56.2–73.7) 0.685
Resting systolic BP (mmHg) 123.5 (118.5–126.5) 119.5 (110.5–123.8) 0.178
Resting diastolic BP (mmHg) 69.5 (64.5–74.2) 66.5 (64.2–70) 0.328
Phe (μmol/L) 43.4 (39.7–58.7) 562.1 (361.8–727.3) < 0.001
Tyr (μmol/L) 47.4 (42.0–55.7) 39.4 (32.5–79.9) 0.719
NE (pg/ml) 344.4 (191.1–414.5) 224.1 (201–265) 0.203
E (pg/ml) 27.4 (21.7–38.9) 34.2 (30.3–41.1) 0.274

Values are presented as median (25th and 75th percentiles)

Abbreviations: HR heart rate, BP blood pressure, Phe phenylalanine, Tyr tyrosine, NE norepinephrine, E epinephrine